JPMorgan Chase & Co’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Sell |
243,710
-39,433
| -14% | -$261K | ﹤0.01% | 3468 |
|
|
2025
Q1 | $2.59M | Sell |
283,143
-15,987
| -5% | -$146K | ﹤0.01% | 3095 |
|
|
2024
Q4 | $3.14M | Buy |
299,130
+45,390
| +18% | +$477K | ﹤0.01% | 3110 |
|
|
2024
Q3 | $3.03M | Buy |
253,740
+176,442
| +228% | +$2.11M | ﹤0.01% | 2964 |
|
|
2024
Q2 | $444K | Sell |
77,298
-29,208
| -27% | -$168K | ﹤0.01% | 3911 |
|
|
2024
Q1 | $554K | Buy |
106,506
+49,697
| +87% | +$258K | ﹤0.01% | 3905 |
|
|
2023
Q4 | $299K | Buy |
56,809
+56,534
| +20,558% | +$298K | ﹤0.01% | 4182 |
|
|
2023
Q3 | $908 | Sell |
275
-1,504
| -85% | -$4.97K | ﹤0.01% | 5700 |
|
|
2023
Q2 | $5.14K | Sell |
1,779
-104,479
| -98% | -$302K | ﹤0.01% | 5272 |
|
|
2023
Q1 | $114K | Sell |
106,258
-235,442
| -69% | -$253K | ﹤0.01% | 4592 |
|
|
2022
Q4 | $892K | Sell |
341,700
-10,728
| -3% | -$28K | ﹤0.01% | 3428 |
|
|
2022
Q3 | $2.47M | Sell |
352,428
-9,355
| -3% | -$65.5K | ﹤0.01% | 2786 |
|
|
2022
Q2 | $2.47M | Sell |
361,783
-852
| -0.2% | -$5.81K | ﹤0.01% | 2870 |
|
|
2022
Q1 | $5.11M | Sell |
362,635
-40,458
| -10% | -$570K | ﹤0.01% | 2542 |
|
|
2021
Q4 | $5.84M | Buy |
403,093
+35,617
| +10% | +$516K | ﹤0.01% | 2476 |
|
|
2021
Q3 | $5.2M | Sell |
367,476
-16,976
| -4% | -$240K | ﹤0.01% | 2549 |
|
|
2021
Q2 | $6.77M | Buy |
384,452
+362,855
| +1,680% | +$6.39M | ﹤0.01% | 2437 |
|
|
2021
Q1 | $330K | Buy |
+21,597
| New | +$330K | ﹤0.01% | 4249 |
|